Onto Innovation Inc.
Onto Innovation Inc. (ONTO) Financial Performance & Income Statement Overview
Explore the financials of Onto Innovation Inc. (ONTO), including yearly and quarterly data on income, cash flow, and balance sheets.
Onto Innovation Inc. (ONTO) Income Statement & Financial Overview
Analyze Onto Innovation Inc.’s ONTO earnings with segmented quarterly and yearly financial statement figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $266.61M | $263.94M | $252.21M | $242.33M |
Cost of Revenue | $123.37M | $131.53M | $115.83M | $126.50M |
Gross Profit | $143.23M | $132.41M | $136.38M | $115.83M |
Gross Profit Ratio | $0.54 | $0.50 | $0.54 | $0.48 |
R&D Expenses | $28.03M | $34.89M | $28.28M | $27.04M |
SG&A Expenses | $43.62M | $44.96M | $41.92M | $39.25M |
Operating Expenses | $80.10M | $89.95M | $83.31M | $65.67M |
Total Costs & Expenses | $203.47M | $223.85M | $199.14M | $192.17M |
Interest Income | $0.00 | $8.96M | $8.67M | $8.50M |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $0.00 | $12.15M | $17.01M | $16.64M |
EBITDA | $63.13M | $54.61M | $70.08M | $66.80M |
EBITDA Ratio | $0.24 | $0.21 | $0.28 | $0.28 |
Operating Income | $63.13M | $42.46M | $53.07M | $50.16M |
Operating Income Ratio | $0.24 | $0.16 | $0.21 | $0.21 |
Other Income/Expenses (Net) | $8.52M | $8.81M | $7.94M | $8.44M |
Income Before Tax | $71.66M | $51.27M | $61.02M | $57.27M |
Income Before Tax Ratio | $0.27 | $0.19 | $0.24 | $0.24 |
Income Tax Expense | $7.56M | $2.45M | $7.96M | $4.32M |
Net Income | $64.09M | $48.82M | $53.05M | $52.95M |
Net Income Ratio | $0.24 | $0.18 | $0.21 | $0.22 |
EPS | $1.30 | $0.99 | $1.07 | $1.07 |
Diluted EPS | $1.30 | $0.98 | $1.07 | $1.07 |
Weighted Avg Shares Outstanding | $49.18M | $49.37M | $49.43M | $49.34M |
Weighted Avg Shares Outstanding (Diluted) | $49.41M | $49.63M | $49.69M | $49.67M |
The company's financials show resilient growth, with revenue advancing from $242.33M in Q2 2024 to $266.61M in Q1 2025. Gross profit remained healthy with margins at 54% in Q1 2025 compared to 48% in Q2 2024. Operating income hit $63.13M last quarter, sustaining a consistent 24% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $63.13M. Net income rose to $64.09M, while earnings per share reached $1.30. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan